Finance

Lists
Outlook: 55.6% bullish·5.6% bearish
Go to analysis
SUPN:NASDAQ
Supernus Pharmaceuticals Inc
$41.92
0.00%
(0.00) 1D
Oct 30, 3:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SUPN...
Mkt. cap
2.44B
Avg. vol.
974.94K
Volume
0.00
52-wk high
$59.68
52-wk low
$37.54
EPS
-$1.91
Beta
0.55
Shares outstanding
58.24M
No. of employees
778
Mkt. cap
2.44B
Avg. vol.
974.94K
Volume
0.00
52-wk high
$59.68
52-wk low
$37.54
EPS
-$1.91
Beta
0.55
Shares outstanding
58.24M
No. of employees
778
News stories
From web sources and news partners
About Supernus Pharmaceuticals Inc
CEOJack A. Khattar
Employees778
Founded2005
HeadquartersRockville, Maryland, United States
SectorPharmaceutical industry
Websitesupernus.com
Analyst ratings
Based on 3 analysts giving stock ratings to SUPN in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SUPN in the last 3 months.
Highest
Current $41.92
$65.00 (+55.06%)
Average
$60.00 (+43.13%)
Lowest
$55.00 (+31.20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chi Meng Fong
Bank of America Securities
Buy
Maintained
-
-
10/30/2026
Annabel Samimy
Stifel Nicolaus
Hold
Maintained
$55.00
+31.2%
10/30/2026
Stacy Ku
TD Cowen
Buy
Maintained
$65.00
+55.1%
10/21/2026
David Amsellem
Piper Sandler
Buy
Reiterated
$66.00
+57.4%
07/27/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
$63.00
+50.3%
07/13/2026
Unknown Analyst
Jefferies
Buy
Maintained
$65.00
+55.1%
07/10/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$67.00
+59.8%
07/09/2026
Pavan Patel
Bank of America Securities
Buy
Maintained
$65.00
+55.1%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
211.57M
207.70M
219.06M
226.77M
Cost of goods sold
50.83M
62.83M
63.13M
52.77M
Cost of revenue
50.83M
62.83M
63.13M
52.77M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
124.44M
126.67M
136.04M
134.26M
Operating expense
148.96M
152.32M
161.37M
157.48M
Total operating expenses
199.80M
215.15M
224.50M
210.25M
Operating income
11.77M
-7.44M
-5.44M
16.52M
Other non operating income
-
-
-
-
EBT including unusual items
-1.91M
-5.95M
-57.65M
22.71M
EBT excluding unusual items
14.24M
-5.06M
-5.13M
18.05M
Income tax expense
2.19M
-3.66M
723.00K
1.80M
Effective tax rate
-114.47%
61.46%
-1.25%
7.91%
Other operating expenses
-
-
-
-
Net income
-4.10M
-2.29M
-58.37M
20.91M
Net profit margin
-1.94%
-1.10%
-26.65%
9.22%
Earnings per share
0.88
0.21
0.53
0.88
Interest and investment income
2.46M
2.38M
2.63M
2.25M
Interest expense
-
-
-2.32M
-718.00K
Net interest expenses
2.46M
2.38M
315.00K
1.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
36.79M
18.69M
20.30M
40.15M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps